Back to previous section

Kenvue shares jump as activist investor Starboard buys in

Shares in American consumer health products group Kenvue were surging on Monday morning on reports that activist investor Starboard Value has amassed a "sizeable stake" in the company.

  • Kenvue Inc
  • 21 October 2024 14:50:17

Source: Sharecast

According to the Wall Street Journal, Starboard wants to boost the share price of Kenvue, which has underperformed the wider sector since the start of 2024.

The report, citing people familiar with the matter, suggested Starboard would push Kenvue's management to "make changes", but did not specify what the investment firm had in mind.

The size of the stake was not disclosed, but Starboard chief executive Jeff Smith is expected to appear at the 13D Monitor Active-Passive Investor Summit in New York on Tuesday and could unveil details there, the WSJ reported.

Tylenol and Aveeno maker Kenvue, the former consumer healthcare arm of Johnson & Johnson that was spun out in 2023, was trading 6.4% higher at $23.11 by 0944 ET.

As of Friday's closing price of $21.72, the stock had barely changed since the start of the year, compared with a 23% gain on the S&P 500.

Compare our accounts

If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.

View our accounts

Lloyds Bank is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.

Important legal information

Lloyds and Lloyds Bank are trading names of Halifax Share Dealing Limited. The Lloyds Bank Direct Investments Service is operated by Halifax Share Dealing Limited. Registered Office: Trinity Road, Halifax, West Yorkshire, HX1 2RG. Registered in England and Wales no. 3195646. Halifax Share Dealing Limited is authorised and regulated by the Financial Conduct Authority, 12 Endeavour Square, London, E20 1JN under registration number 183332. A Member of the London Stock Exchange and an HM Revenue & Customs Approved ISA Manager.

Logo Allfunds

The information contained within this website is provided by Allfunds Digital, S.L.U. acting through its business division Digital Look Ltd unless otherwise stated. The information is not intended to be advice or a recommendation to buy, sell or hold any of the shares, companies or investment vehicles mentioned, nor is it information meant to be a research recommendation. This is a solution powered by Allfunds Digital, S.L.U. acting through its business division Digital Look Ltd incorporating their prices, data news, charts, fundamentals and investor tools on this site. Terms and conditions apply. Prices and trades are provided by Allfunds Digital, S.L.U. acting through its business division Digital Look Ltd and are delayed by at least 15 minutes.

FE fundinfo Logo

Data provided by FE fundinfo. Care has been taken to ensure that the information is correct, but FE fundinfo neither warrants, represents nor guarantees the contents of information, nor does it accept any responsibility for errors, inaccuracies, omissions or any inconsistencies herein. Past performance does not predict future performance, it should not be the main or sole reason for making an investment decision. The value of investments and any income from them can fall as well as rise.

Refinitiv Logo

© 2025 Refinitiv, an LSEG business. All rights reserved.